Product Images Hysingla Er

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Hysingla Er NDC 59011-274 by Purdue Pharma Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

20 mg - 303512 0B

20 mg - 303512 0B

30 mg - 303513 0B

30 mg - 303513 0B

40 mg - 303514 0B

40 mg - 303514 0B

60 mg - 303515 0B

60 mg - 303515 0B

80 mg - 303516 0B

80 mg - 303516 0B

This is not available. The text appears to be a random combination of alphanumeric characters, symbols, and gibberish words that cannot be used to generate a useful description.*

100 mg - 303517 0B

100 mg - 303517 0B

120 mg - 303518 0B

120 mg - 303518 0B

This is a pharmaceutical product with a National Drug Code of 59011-277-60. There is also a series of alphanumeric characters and numbers that do not provide any useful information that can be deciphered.*

figure-1 - figure 1

figure-1 - figure 1

figure-2 - figure 2

figure-2 - figure 2

figure-3 - figure 3

figure-3 - figure 3

This is a chart displaying plasma concentration levels (in ng/ml) of hydrocodone over a period of time (in hours). Two different types of medication were tested: Hysingla ER 30mg (taken once a day for 3 days) and IR Hydrosodore Bitatrate 7.5mg (taken once every 4 hours for 3 days). The chart shows the levels of both medications decreasing over time.*

figure-4 - figure 4

figure-4 - figure 4

hydrocodone-bitartrate-structure - hydrocodone bitartrate structure

hydrocodone-bitartrate-structure - hydrocodone bitartrate structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.